9AT: LYNX1 CAPITAL MANAGEMENT LP

other names

LYNX1 CAPITAL MANAGEMENT LP

Adviser Profile

As of Date	03/31/2026
Registration	SEC, Approved, 04/05/2023
Other registrations (5)	SEC, ERA - Withdrawn, 03/03/2023 Puerto Rico, ERA - Withdrawn, 03/03/2023 Puerto Rico, ERA - Active, 02/04/2022 SEC, ERA - Active, 10/13/2021 SEC, Terminated, 12/11/2020
Former registrations	LYNX1 CAPITAL MANAGEMENT LP LYNX1 CAPITAL MANAGEMENT LP
ADV Location	DORADO, PR, United States
Contact Info	929 xxxxxxx

AUM^*	626,680,245 102%
of that, discretionary	626,680,245 102%
Private Fund GAV^*	576,777,186 106%
Avg Account Size	125,336,049 102%
SMA’s	No
Private Funds	5

Adviser Type

- Large advisory firm

Number of Employees 5

of those in investment advisory functions 4 300%

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

SEC Fund Type	Count	GAV
Fund TypeHedge Fund	Count4	GAV$576,777,186
Fund TypePrivate Equity Fund	Count1	GAV$

Adviser	Hedge Fund	Liquidity Fund	Private Equity Fund	Real Estate Fund	Securitized Asset Fund	Venture Capital Fund	Other Fund	Total Private Fund GAV	AUM	#Funds
Adviser J.H. LANE PARTNERS, LP	Hedge Fund276.0m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV276.0m	AUM276.0m	#Funds5
Adviser ROSENWALD CAPITAL MANAGEMENT, INC.	Hedge Fund158.3m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV158.3m	AUM248.1m	#Funds2
Adviser KELLY PARK INVESTMENT LLC	Hedge Fund108.9m	Liquidity Fund-	Private Equity Fund32.6m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV141.5m	AUM241.5m	#Funds5
Adviser SEASON INVESTMENTS, LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV-	AUM159.7m	#Funds-
Adviser METAVASI CAPITAL LP	Hedge Fund419.7m	Liquidity Fund-	Private Equity Fund862.9k	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV420.6m	AUM420.6m	#Funds4
Adviser CATALYST WEALTH MANAGEMENT	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV-	AUM71.7m	#Funds-
Adviser TAH MANAGEMENT, LP	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV-	AUM165.8m	#Funds-
Adviser MAQRO ADVISORS LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund94.1m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund32.0m	Total Private Fund GAV126.1m	AUM174.4m	#Funds10
Adviser OXFORD GATE MANAGEMENT, LLC	Hedge Fund90.9m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV90.9m	AUM90.9m	#Funds3
Adviser SEGRA CAPITAL MANAGEMENT, LLC	Hedge Fund592.8m	Liquidity Fund-	Private Equity Fund277.9m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund30.3m	Total Private Fund GAV901.0m	AUM820.7m	#Funds10

Stock Ticker	Stock Name	$ Position	% Position	$ Change	# Change
Stck Ticker86150R107	Stock NameSTOKE THERAPEUTICS INC	$ Position$155,105,193	% Position25.00%	$ Change-10.00%	# Change-12.00%
Stck TickerG3855L106	Stock NameGH RESEARCH PLC	$ Position$151,331,829	% Position24.00%	$ Change15.00%	# Change3.00%
Stck Ticker230031106	Stock NameCULLINAN THERAPEUTICS INC	$ Position$127,371,335	% Position20.00%	$ Change37.00%	# Change0.00%
Stck Ticker00847X104	Stock NameAGIOS PHARMACEUTICALS INC	$ Position$88,349,345	% Position14.00%	$ Change3976.00%	# Change3180.00%
Stck Ticker24823R105	Stock NameDENALI THERAPEUTICS INC	$ Position$36,101,818	% Position6.00%	$ Change26.00%	# Change8.00%
Stck Ticker12529R107	Stock NameC4 THERAPEUTICS INC	$ Position$18,407,112	% Position3.00%	$ Change36.00%	# Change-1.00%
Stck Ticker500946108	Stock NameKORRO BIO INC	$ Position$17,413,511	% Position3.00%	$ Change221.00%	# Change127.00%
Stck Ticker64136E102	Stock NameNEUPHORIA THERAPEUTICS INC	$ Position$3,562,585	% Position1.00%	$ Change5.00%	# Change0.00%
Stck Ticker702712209	Stock NamePASSAGE BIO INC	$ Position$4,896,076	% Position1.00%	$ Change-33.00%	# Change0.00%
Stck Ticker74019P207	Stock NamePRECISION BIOSCIENCES INC	$ Position$5,418,122	% Position1.00%	$ Change31.00%	# Change-1.00%

Brochure Summary

Overview

Lynx1 Capital Management LP (“LCM”) is a Delaware limited partnership that was formed in May 2020. Lynx1 Capital Advisors LLC (“LCA”), its relying adviser, is a Puerto Rico limited liability company that was formed in August 2020. LCM and LCA are jointly referred to herein as the “Firm.” The Firm is principally owned and controlled by Weston Nichols, the Firm’s Chief Investment Officer (the “CIO”). LCM provides discretionary investment advice to the following private funds (together, the “Flagship Funds”): (i) Lynx1 Onshore Fund LP (the “Onshore Fund”) and (ii) Lynx1 Master Fund LP (the “Master Fund”). The Onshore Fund is a feeder fund that invests through the Master Fund. The Firm also provides discretionary investment advice to Lynx1 Opportunity Fund I LP (the “Opportunity Fund” and collectively with the Flagship Funds, the “Funds”). The Firm also sub-advises a fund through a separately managed account (the “SMA”). LCA serves as the sub-adviser to the Funds. The Firm may also provide investment advice to additional private funds and expects to provide investment advice to SMAs primarily for institutional, non-retail investors. References

throughout this document to “clients” refer to the Funds and any other private funds and SMAs that the Firm may advise in the future. Client accounts are managed in accordance with their own investment and trading objectives, as described in their respective offering documents, governing agreements or advisory agreements (collectively, the “Governing Documents”), as applicable. The Firm does not permit investors in the Funds to impose limitations on the investment activities described in the Funds’ Governing Documents. Under certain circumstances, the Firm may contract with a client to adhere to limited risk and/or operating guidelines imposed by that client. The Firm would negotiate such arrangements on a case-by-case basis. (See Item 16 - Investment Discretion.) Lynx1 Fund GP LLC, one of the Firm’s related persons (the “Lynx1 GP”), serves as the general partner to certain Funds. The Firm does not participate in wrap fee programs. As of December 31, 2023, the Firm managed $268,343,489 of regulatory assets under management on a discretionary basis. The Firm does not manage any assets on a non-discretionary basis.

LYNX1 CAPITAL MANAGEMENT LP

Related Companies

Adviser Profile

Adviser Type

Client Types

Advisory Activities

Compensation Arrangments

Reported AUM

Private Funds

Employees

Private Funds Structure

Similar advisers

Top Holdings

Brochure Summary

Overview